Page last updated: 2024-08-23

mefloquine and Opisthorchiasis

mefloquine has been researched along with Opisthorchiasis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Keiser, J; Odermatt, P; Tesana, S1
Akkhavong, K; Hatz, C; Keiser, J; Odermatt, P; Sayasone, S; Soukhathammavong, P; Vonghachack, Y; Vounatsou, P1

Trials

1 trial(s) available for mefloquine and Opisthorchiasis

ArticleYear
Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial.
    The Lancet. Infectious diseases, 2011, Volume: 11, Issue:2

    Topics: Adolescent; Animals; Anthelmintics; Artemisinins; Artesunate; Child; Drug Therapy, Combination; Female; Humans; Laos; Male; Mefloquine; Opisthorchiasis; Opisthorchis; Parasite Egg Count; Phenylenediamines; Praziquantel; Treatment Outcome

2011

Other Studies

1 other study(ies) available for mefloquine and Opisthorchiasis

ArticleYear
Dose-response relationships and tegumental surface alterations in Opisthorchis viverrini following treatment with mefloquine in vivo and in vitro.
    Parasitology research, 2009, Volume: 105, Issue:1

    Topics: Administration, Oral; Animal Structures; Animals; Anthelmintics; Cricetinae; Dose-Response Relationship, Drug; Humans; Male; Mefloquine; Mesocricetus; Microscopy, Electron, Scanning; Opisthorchiasis; Opisthorchis; Survival Analysis

2009